These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32738178)

  • 61. PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells.
    Couty JP; Rampon C; Leveque M; Laran-Chich MP; Bourdoulous S; Greenwood J; Couraud PO
    J Neurochem; 2007 Oct; 103(2):793-801. PubMed ID: 17662049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease.
    Hsu J; Serrano D; Bhowmick T; Kumar K; Shen Y; Kuo YC; Garnacho C; Muro S
    J Control Release; 2011 Feb; 149(3):323-31. PubMed ID: 21047542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo regulation of PECAM-1 activity during acute endothelial dysfunction in the rat mesenteric microvasculature.
    Scalia R; Lefer AM
    J Leukoc Biol; 1998 Aug; 64(2):163-9. PubMed ID: 9715254
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes.
    Treutiger CJ; Heddini A; Fernandez V; Muller WA; Wahlgren M
    Nat Med; 1997 Dec; 3(12):1405-8. PubMed ID: 9396614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.
    Bhowmick T; Berk E; Cui X; Muzykantov VR; Muro S
    J Control Release; 2012 Feb; 157(3):485-92. PubMed ID: 21951807
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis.
    Zaitsev S; Kowalska MA; Neyman M; Carnemolla R; Tliba S; Ding BS; Stonestrom A; Spitzer D; Atkinson JP; Poncz M; Cines DB; Esmon CT; Muzykantov VR
    Blood; 2012 May; 119(20):4779-85. PubMed ID: 22493296
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunotargeting of glucose oxidase: intracellular production of H(2)O(2) and endothelial oxidative stress.
    Gow AJ; Branco F; Christofidou-Solomidou M; Black-Schultz L; Albelda SM; Muzykantov VR
    Am J Physiol; 1999 Aug; 277(2):L271-81. PubMed ID: 10444521
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating IgSF proteins inhibit adhesion of antibody targeted microspheres to endothelial inflammatory ligands.
    Kerby MB; Urban JC; Mouallem L; Tripathi A
    Appl Biochem Biotechnol; 2009 Oct; 159(1):208-20. PubMed ID: 19140030
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.
    Hsu J; Rappaport J; Muro S
    Pharm Res; 2014 Jul; 31(7):1855-66. PubMed ID: 24558007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factor.
    Han J; Shuvaev VV; Muzykantov VR
    J Pharmacol Exp Ther; 2011 Jul; 338(1):82-91. PubMed ID: 21474567
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo.
    Rosenblum WI; Nelson GH; Wormley B; Werner P; Wang J; Shih CC
    Stroke; 1996 Apr; 27(4):709-11. PubMed ID: 8614936
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.
    Kennel SJ; Woodward JD; Rondinone AJ; Wall J; Huang Y; Mirzadeh S
    Nucl Med Biol; 2008 May; 35(4):501-14. PubMed ID: 18482688
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The influence of erythropoietin (Epo) on intercellular adhesion molecule-1 (ICAM-1, CD54) and platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) expression on human umbilical vein endothelial cells (HUVEC) induced by tumor necrosis factor-alpha (TNF-alpha)].
    Szczepański M; Kamianowska M; Wnuczko K; Pietruczuk M; Wołczyński S
    Wiad Lek; 2007; 60(1-2):22-7. PubMed ID: 17607964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.
    Khoshnejad M; Shuvaev VV; Pulsipher KW; Dai C; Hood ED; Arguiri E; Christofidou-Solomidou M; Dmochowski IJ; Greineder CF; Muzykantov VR
    Bioconjug Chem; 2016 Mar; 27(3):628-37. PubMed ID: 26718023
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.
    Cosimi AB; Conti D; Delmonico FL; Preffer FI; Wee SL; Rothlein R; Faanes R; Colvin RB
    J Immunol; 1990 Jun; 144(12):4604-12. PubMed ID: 1972162
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress.
    Atochina EN; Balyasnikova IV; Danilov SM; Granger DN; Fisher AB; Muzykantov VR
    Am J Physiol; 1998 Oct; 275(4):L806-17. PubMed ID: 9755114
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature.
    Ding BS; Gottstein C; Grunow A; Kuo A; Ganguly K; Albelda SM; Cines DB; Muzykantov VR
    Blood; 2005 Dec; 106(13):4191-8. PubMed ID: 16144802
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monocytic thrombomodulin promotes cell adhesion through interacting with its ligand, Lewis
    Lin WL; Chen CC; Shi GY; Ma CY; Chang CF; Wu HL
    Immunol Cell Biol; 2017 Apr; 95(4):372-379. PubMed ID: 27808085
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.
    Adams GP; Schier R; McCall AM; Crawford RS; Wolf EJ; Weiner LM; Marks JD
    Br J Cancer; 1998 May; 77(9):1405-12. PubMed ID: 9652755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.